Home › Funds › Avoro Capital Advisors LLC › RVMD
Avoro Capital Advisors LLC position in RVMD
REVOLUTION MEDICINES INC · Health Care
Avoro Capital Advisors LLC reported holding 2,145,000 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$440.3M, representing 4.56% of its reported portfolio and ranking #8 among its reported holdings. Avoro Capital Advisors LLC has disclosed RVMD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Avoro Capital Advisors LLC's RVMD position evolved
Avoro Capital Advisors LLC first disclosed a stake in RVMD in Q4 2025 at 2,170,000 shares (US$172.8M). The position peaked in Q3 2026 at 2,145,000 shares, worth US$440.3M. Across 4 filings, Avoro Capital Advisors LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,145,000 shares valued at US$440.3M — a reduction of -152,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 2.17M | $172.84M | New |
| Q1 2026 | 2.34M | $228.00M | Add |
| Q2 2026 | 2.30M | $430.18M | Reduce |
| Q3 2026 | 2.15M | $440.28M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RVMD and 13F data
RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 54 other funds we track also report a position in RVMD — the largest reported positions include FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.75B), Farallon Capital Management (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RVMD
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.42M sh · $2.75B · Q3 2026
- Farallon Capital Management 13.55M sh · $2.54B · Q2 2026
- BAKER BROS. ADVISORS LP 11.44M sh · $2.14B · Q2 2026
- Darwin Global Management, Ltd. 10.63M sh · $2.05B · Q2 2026
- Nextech Invest Ltd. 7.60M sh · $1.42B · Q2 2026
- Paradigm Biocapital Advisors LP 6.22M sh · $1.28B · Q3 2026
- Janus Henderson Group 9.77M sh · $949.54M · Q1 2026
- BVF INC/IL 2.97M sh · $555.32M · Q2 2026
- Alphabet Inc. 2.67M sh · $548.85M · Q3 2026
- Casdin Capital 2.58M sh · $482.68M · Q2 2026
- Assenagon Asset Management S.A. 2.18M sh · $447.71M · Q3 2026
- Nearwater Capital Markets, Ltd 1.79M sh · $367.00M · Q3 2026
More on Avoro Capital Advisors LLC
FAQ
How long has Avoro Capital Advisors LLC held RVMD?
Avoro Capital Advisors LLC has disclosed RVMD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Avoro Capital Advisors LLC's current position in RVMD?
As of Q3 2026, Avoro Capital Advisors LLC holds 2.15M shares of RVMD (REVOLUTION MEDICINES INC), valued at $440.28M, representing 4.56% of its reported portfolio and ranking #8.
Has Avoro Capital Advisors LLC been buying or selling RVMD?
In the latest 13F filing (Q3 2026), Avoro Capital Advisors LLC reduced its position in RVMD. The position peaked in Q3 2026 at 2.15M shares.
Which other funds hold RVMD?
Other major institutional holders of RVMD include FARALLON CAPITAL MANAGEMENT, L.L.C., Farallon Capital Management, BAKER BROS. ADVISORS LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.